HTC
BPMC

Hershey Trust Company’s Blueprint Medicines BPMC Stock Holding History

Hershey Trust Company’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-299
Closed -$6K – 13
2016
Q2 		$6K Buy
+299
New +$5.43K ﹤0.01% 13

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Hershey Trust Company's BPMC Position: Q3 2016 in Review

Hershey Trust Company sold out of Blueprint Medicines (BPMC) in Q3 2016, closing a stake of 299 shares — an estimated $6K sold.

Hershey Trust Company first reported a position in BPMC in Q2 2016 and held it in 1 quarter. The position peaked at $6K in Q2 2016. 87 funds tracked by Wall St. Rank hold BPMC as of Q3 2016.

  • Hershey Trust Company reported no remaining Blueprint Medicines position as of Q3 2016 after selling out during the quarter.
  • Hershey Trust Company sold 299 Blueprint Medicines shares in Q3 2016, an estimated $6K.
  • Hershey Trust Company first reported a position in Blueprint Medicines in Q2 2016 and held it in 1 quarter.
  • Hershey Trust Company's Blueprint Medicines position peaked at $6K in Q2 2016.
  • 87 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2016.

Based on Hershey Trust Company's 13F filing for Q3 2016, filed 21 Oct 2016.